Company Profile

Perseon Corporation (AKA: BSD Medical Corporation)
Profile last edited on: 12/1/2023      CAGE: 1DBZ6      UEI: GG95JB5MBRE7

Business Identifier: Highly focused radiofrequency or microwave ablation energy
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2188 West 2200 South
Salt Lake City, UT 84119
   (801) 972-5555
Location: Single
Congr. District: 02
County: Salt Lake

Public Profile

Renamed Perseon Corporation in c. 2015, BSD Medical Corporation (NASDAQ) had been organized around treatment of cancer and benign diseases through heat therapy delivered using focused radiofrequency (RF) and microwave energy. Shortly thereafter that name change, the firm was acquired by Galil Corporation an Israeli developer of oncology cryoablation technology. Developing technology and products for thermal ablation and hyperthermia cancer therapy through various techniques, to include thermal ablation that ablates soft tissues at high temperatures through focused microwave energy; and superficial hyperthermia, which non-invasively treats cancerous tumors located within a few centimeters of the surface of the body, including melanoma and recurrent breast cancer, the company also developed internal or interstitial hyperthermia that treats tumors in combination with internal radiation therapy; and deep hyperthermia, which non-invasively treats tumors located deep within the body. It provides MicroThermX microwave ablation systems for the ablation of soft tissue; BSD-500 Hyperthermia System that delivers superficial or interstitial hyperthermia therapy or both; and BSD-2000 Hyperthermia System, which non-invasively delivers localized therapeutic heating to solid tumors by applying RF energy to certain cancerous tumors, as well as BSD-2000/3D and BSD-2000/3D/MR systems. The company serves clinics, hospitals, and institutes in the United States and internationally.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1996 2 NIH $513,565
Project Title: Steerable hyperthermia EM phased array applicator
1985 1 NIH $50,000
Project Title: Development and testing of hyperthermia equipment

Key People / Management

  Hyrum A Mead -- President

  Paul F Turner